| This report contains COVID-19 specific updates.
Infusion Pumps and Devices: Technologies and Global Markets
Report Highlights
The global market for infusion pumps was valued at $9.8 billion in 2021 and is estimated to grow from $10.3 billion in 2022 to $15.0 billion in 2027 with compound annual growth rate (CAGR) of 7.7% for the period of 2022-2027.
Report Includes
- 34 data tables and 69 additional tables.
- An overview of the global market and technologies for infusion pumps and devices
- Estimation of the market size and analyses of global market trends, with data from 2021, estimates for 2022, with projections of compound annual growth rates (CAGRs) through 2027
- Coverage of medical, scientific, technological, social, and economic issues associated with this market and evaluation of the current market and variable factors of each category of diagnostic or therapeutic product
- Discussion of changes to the regulatory environment and delivery infrastructure due to healthcare reform in the U.S. and other countries, and the rapid changes in product offerings following a series of high-profile product recalls
- Examination of the transition to "smart pump" technology and the complex systems that complement and compete with infusion pumps as modes of treatment
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies and a relevant patent analysis
- Company profiles of major players, including Intera Oncology, ICU Medical Inc, Cardinal Health and ZYNO Solution LLC
Report Scope
This report aims to provide a comprehensive picture of the global market for infusion pumps, with both quantitative and qualitative data, to help readers develop business/growth strategies, assess the market landscape, analyze their position in the current marketplace, and make informed business decisions regarding infusion pumps.
An in-depth analysis of the global infusion pumps market includes historical data and market projections on sales by pump type, therapeutic application, end user, and region. The analysis describes the different types of infusion pumps (general purpose and specialty) and their current and historical market revenues. The general purpose infusion pumps are categorized into large volume, syringe, electronic ambulatory, and elastomeric. The specialty infusion pumps are divided into insulin infusion pumps, enteral infusion pumps, PCA infusion pumps, and implantable infusion pumps.
This report also examines therapeutic applications for infusion pumps (diabetes management, oncology, pain management/analgesia, nutrition, and other applications) and end users of infusion pumps (hospitals, home care and alternate site care settings).
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors and their respective market ranks. The report also discusses technological trends and new product developments.
Analyst Credentials
BCC Publishing Staff comprises expert analysts who are skilled in conducting primary research, secondary research and data analysis and have decades of combined experience covering a wide range of industries, including healthcare, advanced materials and emerging technologies. Collectively, the team represents a diverse set of educational achievements with individual graduate work completed in fields such as microbiology, electrical engineering, business administration and surgery, among others.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2021 | ||||||||||||||||||||||||
| Forecast period considered | 2022–2027 | ||||||||||||||||||||||||
| Base year market size | $9.8 billion | ||||||||||||||||||||||||
| Market size forecast | $15.0 billion | ||||||||||||||||||||||||
| Growth rate | CAGR of 7.7% from 2022 to 2027 | ||||||||||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||||||||||
| Segments covered | Product Type, Region, Company, End User, Therapeutic Application | ||||||||||||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) | ||||||||||||||||||||||||
| Countries covered | United States., Canada., Germany., France., U.K., Italy., Rest of Europe (Spain, Switzerland, Denmark, Norway, Poland, Belgium, Austria, Netherlands, Sweden, Russia)., China., Japan., India., Rest of Asia-Pacific (Australia, South Korea, New Zealand, Taiwan, Singapore, Malaysia, Thailand, Philippines, Indonesia)., Latin America., Middle East and Africa. | ||||||||||||||||||||||||
| Key Market Drivers |
|
||||||||||||||||||||||||
| Companies studied |
|
Report Highlights
The global market for infusion pumps and devices reached $18.5 billion in 2015. The market should reach $19.6 billion in 2016 and nearly $25.8 billion by 2021, growing at a compound annual growth rate (CAGR) of 5.6% from 2016 to 2021.
Report Includes
- An overview of the global market for infusion pumps used for continuous or intermittent administration of medications (including antibiotics), nutrients, and analgesics.
- Analyses of global market trends with data from 2014 and 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021.
- Coverage of medical, scientific, technological, social, and economic issues associated with this market.
- Evaluation of the current market and variable factors of each category of diagnostic or therapeutic product.
- Discussion of changes to the regulatory environment and delivery infrastructure due to healthcare reform in the U.S. and other countries, and the rapid changes in product offerings following a series of high-profile product recalls.
- Examination of the transition to "smart pump" technology and the complex systems that complement and compete with infusion pumps as modes of treatment.
- Profiles of major players in the industry.
Report Highlights
The global revenue for the infusion pumps and devices market reached $17.8 billion in 2012. This market is expected to grow to $18.7 billion in 2013 and then to $23.7 billion by 2018 at a compound annual growth (CAGR) of 4.8% from 2013-2018.
Report Includes
- An overview of the global market for infusion pumps used for continuous or intermittent administration of medications (including antibiotics), nutrients, and analgesics
- Analyses of global market trends, with data from 2011 and 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018
- Coverage of medical, scientific, technological, social, and economic issues associated with this market
- Evaluation of the current market and variable factors of each category of diagnostic or therapeutic product
- Discussion of changes to the regulatory environment and delivery infrastructure due to healthcare reform in the U.S. and other countries, and the rapid changes in product offerings following a series of high-profile product recalls
- Examination of the transition to “smart pump” technology and the complex systems that complement and compete with infusion pumps as modes of treatment
- Comprehensive company profiles of major players in the industry.
Report Highlights
- Global spending on infusion pumps were $6.4 billion in 2008 which increased to $7 billion in 2009. This is projected to reach $9.6 billion in 2014 at a compound annual growth rate (CAGR) of 6.5%
- Spending alone in USA was nearly $3.3 billion in 2008 which increased to $3.6 billion in 2009. This is projected to reach $4.8 billion in 2014 at a compound annual growth rate (CAGR) of 5.8%
- Spending in Europe was $1.9 billion in 2008, which increased slightly in 2009 to $2 billion. This market is projected to reach approx $2.8 billion in 2014, for a 5-year CAGR of 6.4%.